期刊文献+

初诊2型糖尿病患者尿微量白蛋白/肌酐比值异常的发生率及危险因素分析 被引量:5

Prevalence and risk factors of abnormal urine albumin/creatinine ratio in new-diagnosed type 2 diabetes mellitus patients
下载PDF
导出
摘要 目的分析初诊2型糖尿病患者尿微量白蛋白/肌酐比值(ACR)异常的发生率及危险因素。方法 2008年9月至2009年12月我院内分泌科收治的初诊2型糖尿病患者245例,测定空腹血糖(FPG),葡萄糖耐量试验、血脂、肾功能及尿ACR等。分别根据患者年龄、糖化血红蛋白(HbA1c)及尿ACR水平进行分层。采用t检验、方差分析、多元逐步回归分析等方法进行统计学分析。结果①本研究人群中,尿ACR的异常率为21.6%,其中微量白蛋白尿20.4%,大量白蛋白尿1.2%。②不同年龄组患者尿ACR水平〈40岁组(26.4±34.2)mg/g、≥40~50岁组(33.7±68.5)mg/g、≥50~59岁组(38.6±94.9)mg/g、≥60~69岁组(33.9±60.8)mg/g、≥70岁组(48.9±62.4)mg/g,差异无统计学意义(F=0.400,P〉0.05)。③异常尿ACR组FPG、收缩压(SBP)、甘油三酯(TG)、体质量指数(BMI)显著高于正常尿ACR组患者(t值分别为-2.547、-2.144、-2.113、-4.663,P〈0.05或〈0.01),高密度胆固醇(HDL-C)显著低于正常尿ACR组(t=2.216,P〈0.05)。④HbA1c≥6.5%组的尿ACR水平与HbA1c〈6.5%组的差异无统计学意义(t=0.475,P〉0.05),HbA1c≥6.5%组患者合并高血压的尿ACR水平显著高于血压正常患者(t=-2.472,P〈0.05)。HbA1c〈6.5%组患者尿ACR比值水平与BMI、FPG呈正相关(r值分别为0.564、0.559,均P〈0.05);HbA1c≥6.5%组尿ACR水平与SBP、舒张压(DBP)和FPG呈正相关(r值分别为0.186、0.169、0.182,均P〈0.05);⑤多元逐步线性回归分析结果,影响尿ACR的主要因素包括FPG、SBP、肌酐(Cr)。结论初诊2型糖尿病患者尿ACR水平异常的发生不受年龄的影响,与血压及FPG有关。 Objective To analyze the prevalence and risk factors of abnormal urine albumin/creatinine ratio(ACR) in new-diagnosed type 2 diabetes mellitus patients.Methods The fasting plasma glucose(FPG),OGTT,lipid profile,renal function,urine ACR were measured in 245 new-diagnosed type 2 diabetes mellitus patients from September 2008 to December 2009.The subjects were divided into different groups according to age,HbA1c and ACR.Statistic t test,one-way ANOVA and multiple stepwise regression analyses were used for data analysis.Results ①The prevalence of abnormal urine ACR in this cohort was 21.6%,and microalbuminuria was 20.4%,macroalbuminuria was 1.2%.②There was no significant difference in urinary ACR level among different age groups,40 age group ACR(26.4±34.2) mg/g,≥40-50 age group(33.7±68.5) mg/g,≥50-59 age group(38.6±94.9) mg/g,≥60-69 age group(33.9±60.8) mg/g,≥70 age group(48.9±62.4) mg/g(F=0.400,P0.05).③The FPG,systolic blood pressure(SBP),triglyceride(TG),body mass index(BMI) in abnormal ACR group were significantly higher than those of normal ACR group(t=-2.547,-2.144,-2.113,-4.663,P0.05 or 0.01),and the level of high-density lipoprotein cholesterol(HDL-C) was significantly lower than that of normal ACR group(t=2.216,P0.05).④There was no significant difference in urinary ACR level between HbA1c≥6.5% and HbA1c6.5% group(t=0.475,P0.05),and ACR level of HbA1c≥6.5% group with hyertension was significantly higher than that of normal blood pressure(t=-2.472,P0.05).Urinary ACR showed positive correlations with BMI,FPG in HbA1c6.5% group(r=0.564,0.559,both P0.05) and with SBP,diastolic blood pressure(DBP) and FPG in HbA1c≥6.5% group(r=0.186,0.169,0.182,all P0.05).⑤FPG,SBP and creatinine were independent risk factors for urinary ACR according to multiple stepwise regression analysis.Conclusion Urinary ACR level in new-diagnosed type 2 diabetes mellitus patients might be associated with BP and FPG regardless of age.
出处 《临床荟萃》 CAS 2010年第24期2117-2120,共4页 Clinical Focus
关键词 糖尿病 2型 血红蛋白A 糖基化 白蛋白尿 diabetes type 2 hemoglobin A glycosylated albuminuria
  • 相关文献

参考文献11

  • 1American Diabetes Association. Standards of Medical Care in Diabetes-2010[J].Diabetes Care,2010,33(Suppl 1) :S11-S61.
  • 2Adler AI,Stevens RJ, Manley SE, et al. The UKPDS Group: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS64)[J]. Kidney Int,2003,63(1):225-232.
  • 3Younes N, Cleary PA, Steffes MW, et al. Comparison of Urinary Albumin-Creatinine Ratio and Albumin Excretion Rate in the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Study[J].Clin J Am Soc Nephrol,2010,5(7) :1235-1242.
  • 4Chantrel F, Moulin B, Hannedouche T. Blood pressure, diabetes and diabetic nephropathy[J]. Diabetes Metab, 2000, 26(4) :37- 44.
  • 5Gall MA, Hougaard P,Borch--Johnsen K,et al. Risk factors for development of incipient and overt diabetic nephropathy in patients with out-insulin dependent diabetes mellitus: prospective, observational study [J].BMJ, 1997, 314 ( 7083 ) : 783-788.
  • 6Waden J, Forsblom C, Thorn LM, et al. AIC variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes[J].Diabetes, 2009,58( 11 ) : 2649-2655.
  • 7Stratton IM, Cull CA, Adler AI, et al. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observationsl study(UKPDS 75) [J]. Diabetologia,2006,49(8) :1761-1769.
  • 8UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular complications in type 2 diabetes:UKPDS 38[J]. BMJ, 1998,317(7160) : 703-713.
  • 9China's Mainland Microalbuminuria Prevalence Study Group Corresponding author:DU Jin,PAN Chang-yu.Department of Endocrinology,Chinese PLA General Hospital,.中国内地2型糖尿病合并高血压患者微量白蛋白尿检出率调查[J].中华内科杂志,2007,46(3):184-188. 被引量:18
  • 10Bianchi C,Penno G, Daniele G, et al. The metabolic syndrome is related to albuminuria in Type 2 diabetes[J]. Diabet Med, 2008,25(12):1412-1418.

二级参考文献18

  • 1Lebovitz HE, Wiegmann TB, Cnaan A, et al. Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria. Kidney Int Suppl, 1994,45 :S150-155.
  • 2Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 1993,16:434-444.
  • 3Molitch ME, DeFronzo RA, Franz MJ, et al. Diabetic Nephropathy. Diabetes Care,2003,26 Suppl 1 : S94-S98.
  • 4Pan CY, Du J, Hou XX. Comparison of the three methods for urinary albumin determination in Chinese diabetic patients. 18th International Diabetes Federation Congress. Diabetes Metab,2003,29:4S35.
  • 5King H, Aubert BE, Herman WH. Global burden of diabetes,1995-2025: prevalence, numerical estimates, and projections.Diabetes Care, 1998, 21:1414-1431.
  • 6Epstein M, Sowers JR. Diabetes mellitus and hypertension.Hypertension, 1992, 19:403-418.
  • 7Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2004 annual data report: atlas of endstage renal disease in the United States. Am J Kidney Dis, 2005,45(1 Suppl 1) :A5-7.
  • 8Park HY, Schumock GT, Pickard AS, et al. A structured review of the relationship between microalbuminuria and cardiovascular events in patients with diabetes mellitus and hypertension.Pharmacotherapy, 2003, 23: 1611-1616.
  • 9Effects of ramipril on cardiovascular and microvescular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet, 2000, 355:253-259.
  • 10Parring HH, Lehnert H, Brochner-Mortensen J, et al. The erect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med, 2001,345:870-878.

共引文献17

同被引文献30

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部